UNIVERSITY COLLEGE LONDON
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1826-02-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucl.ac.uk
Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL)
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- University College, London
- Target Recruit Count
- 12
- Registration Number
- NCT01459211
- Locations
- 🇬🇧
University College London, London, United Kingdom
🇬🇧Royal Liverpool University Hospital, Liverpool, United Kingdom
MELT - MRI Evaluation of Lymphoma Treatment
- Conditions
- Lymphoma, Hodgkin
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- University College, London
- Target Recruit Count
- 58
- Registration Number
- NCT01459224
- Locations
- 🇬🇧
University College London Hospital (UCLH), London, United Kingdom
Neuroprotection With Phenytoin in Optic Neuritis
- First Posted Date
- 2011-10-13
- Last Posted Date
- 2015-09-09
- Lead Sponsor
- University College, London
- Target Recruit Count
- 92
- Registration Number
- NCT01451593
- Locations
- 🇬🇧
Royal Hallamshire Hospital, Sheffield, United Kingdom
🇬🇧National Hospital for Neurology and Neurosurgery, London, United Kingdom
Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- University College, London
- Target Recruit Count
- 39
- Registration Number
- NCT01415011
- Locations
- 🇬🇧
University College Hospital, London, United Kingdom
🇬🇧Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
🇬🇧Royal Bournemouth Hospital, Bournemouth, United Kingdom
IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
- Conditions
- Thyroid Cancer
- Interventions
- Radiation: I131 1.1 GBq
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University College, London
- Target Recruit Count
- 504
- Registration Number
- NCT01398085
- Locations
- 🇬🇧
Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom
🇬🇧East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom
🇬🇧University College London Hospitals NHS Foundation Trust, London, United Kingdom
Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD).
- Interventions
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2012-06-01
- Lead Sponsor
- University College, London
- Target Recruit Count
- 200
- Registration Number
- NCT01398072
- Locations
- 🇬🇧
Academic Unit of Respiratory Medicine, Royal Free Hospital, London, United Kingdom
MI Mortality Risk and Between-hospital Risk Variation in the United Kingdom and Sweden
- Conditions
- Acute Myocardial Infarction
- First Posted Date
- 2011-05-24
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- University College, London
- Target Recruit Count
- 510863
- Registration Number
- NCT01359033
- Locations
- 🇸🇪
Uppsala Clinial Research Center, Uppsala, Sweden
🇬🇧University College London, London, United Kingdom
A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma
- Conditions
- Malignant Pleural Mesothelioma
- Interventions
- First Posted Date
- 2011-05-13
- Last Posted Date
- 2012-03-22
- Lead Sponsor
- University College, London
- Registration Number
- NCT01353482
Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
- Conditions
- Liver Cancer
- First Posted Date
- 2011-03-28
- Last Posted Date
- 2011-05-13
- Lead Sponsor
- University College, London
- Target Recruit Count
- 412
- Registration Number
- NCT01324076
- Locations
- 🇬🇧
Bristol Royal Infirmary, Bristol, England, United Kingdom
🇬🇧Aintree University Hospital, Liverpool, England, United Kingdom
🇬🇧Southampton General Hospital, Southampton, England, United Kingdom
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2011-03-11
- Last Posted Date
- 2011-12-12
- Lead Sponsor
- University College, London
- Target Recruit Count
- 4
- Registration Number
- NCT01313390
- Locations
- 🇬🇧
UCL Cancer Institute, London, England, United Kingdom